Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1 1

Status

Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Hodgkin Disease 3Lymphoma, Non-Hodgkin 2Leukemia 2Renal Pelvis and Ureter Urothelial Carcinoma 1Recurrence 1Pain 1Lymphoma, T-Cell 1Lymphoma 1Breast Neoplasms 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 13Rituximab 11obinutuzumab 6fludarabine phosphate 6Prednisone 6Magnetic Resonance Spectroscopy 6ibrutinib 5fludarabine 5X-Rays 5Specimen Handling 5Phantoms, Imaging 5Nuclear Medicine Department, Hospital 5Melphalan 5Lenalidomide 5Etoposide 5Doxorubicin 5Biopsy 5tocilizumab 4Whole-Body Irradiation 4venetoclax 3polatuzumab vedotin 3glofitamab 3acalabrutinib 3Vincristine 3Mycophenolic Acid 3Leukapheresis 3Filgrastim 3Cytarabine 3Cyclosporine 3Busulfan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphoma, Non-Hodgkin × pegfilgrastim × 30 days × Clear all
NCT01046825 2026-06-02

Mature B-Cell Lymphoma And Leukemia Study III

St. Jude Children's Research Hospital

Phase 2/3 Active not recruiting
128 enrolled 12 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin

NCT01840566 2026-05-28

High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 1 Active not recruiting
17 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡